Aspire BioPharma Inc. (ASBP)
0.64
0.01 (1.52%)
At close: Mar 24, 2025, 3:19 PM
Company Description
Aspire BioPharma, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing.
The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.
Aspire BioPharma Inc.
| Country | United States |
| IPO Date | Apr 11, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Kraig T. Higginson |
Contact Details
Address: 188 Grand Street, Unit 195 New York, New York United States | |
| Website | https://aspirebiolabs.com/ |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | KYG7207P1037 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Kraig T. Higginson | President, Chief Executive Officer & Chairman of Board |
| Ernest J. Scheidemann Jr. | Chief Financial Officer |
| Stephen E. Quesenberry | General Counsel, Corporate Secretary & Director |